These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

843 related items for PubMed ID: 27320173

  • 1. Relationship of baseline HDL subclasses, small dense LDL and LDL triglyceride to cardiovascular events in the AIM-HIGH clinical trial.
    Albers JJ, Slee A, Fleg JL, O'Brien KD, Marcovina SM.
    Atherosclerosis; 2016 Aug; 251():454-459. PubMed ID: 27320173
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ, Watson KE, Talbert RL.
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The role of niacin in raising high-density lipoprotein cholesterol to reduce cardiovascular events in patients with atherosclerotic cardiovascular disease and optimally treated low-density lipoprotein cholesterol Rationale and study design. The Atherothrombosis Intervention in Metabolic syndrome with low HDL/high triglycerides: Impact on Global Health outcomes (AIM-HIGH).
    AIM-HIGH InvestigatorsAxio Research, LLC, Seattle, WA, USA. ruthm@axioresearch.com.
    Am Heart J; 2011 Mar; 161(3):471-477.e2. PubMed ID: 21392600
    [Abstract] [Full Text] [Related]

  • 10. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.
    AIM-HIGH Investigators, Boden WE, Probstfield JL, Anderson T, Chaitman BR, Desvignes-Nickens P, Koprowicz K, McBride R, Teo K, Weintraub W.
    N Engl J Med; 2011 Dec 15; 365(24):2255-67. PubMed ID: 22085343
    [Abstract] [Full Text] [Related]

  • 11. Efficacy and safety of long-term ezetimibe/simvastatin treatment in patients with familial hypercholesterolemia.
    Avellone G, Di Garbo V, Guarnotta V, Scaglione R, Parrinello G, Purpura L, Torres D, Campisi D.
    Int Angiol; 2010 Dec 15; 29(6):514-24. PubMed ID: 21173733
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome: The IMPROVE-IT Trial.
    Murphy SA, Cannon CP, Blazing MA, Giugliano RP, White JA, Lokhnygina Y, Reist C, Im K, Bohula EA, Isaza D, Lopez-Sendon J, Dellborg M, Kher U, Tershakovec AM, Braunwald E.
    J Am Coll Cardiol; 2016 Feb 02; 67(4):353-361. PubMed ID: 26821621
    [Abstract] [Full Text] [Related]

  • 15. Visit-to-visit variability of lipid measurements as predictors of cardiovascular events.
    Waters DD, Bangalore S, Fayyad R, DeMicco DA, Laskey R, Melamed S, Barter PJ.
    J Clin Lipidol; 2018 Feb 02; 12(2):356-366. PubMed ID: 29310989
    [Abstract] [Full Text] [Related]

  • 16. HDL-C: role as a risk modifier.
    Barter P.
    Atheroscler Suppl; 2011 Nov 02; 12(3):267-70. PubMed ID: 22152280
    [Abstract] [Full Text] [Related]

  • 17. Effect of Extended-Release Niacin on High-Density Lipoprotein (HDL) Functionality, Lipoprotein Metabolism, and Mediators of Vascular Inflammation in Statin-Treated Patients.
    Yadav R, Liu Y, Kwok S, Hama S, France M, Eatough R, Pemberton P, Schofield J, Siahmansur TJ, Malik R, Ammori BA, Issa B, Younis N, Donn R, Stevens A, Durrington P, Soran H.
    J Am Heart Assoc; 2015 Sep 15; 4(9):e001508. PubMed ID: 26374297
    [Abstract] [Full Text] [Related]

  • 18. Lipoprotein Subfractions and Glucose Homeostasis in Prediabetes and Diabetes in Taiwan.
    Hsu H, Hsu P, Cheng MH, Ito Y, Kanda E, Schaefer EJ, Ai M.
    J Atheroscler Thromb; 2019 Oct 01; 26(10):890-914. PubMed ID: 30726792
    [Abstract] [Full Text] [Related]

  • 19. Baseline Low-Density Lipoprotein Cholesterol and Clinical Outcomes of Combining Ezetimibe With Statin Therapy in IMPROVE-IT.
    Oyama K, Giugliano RP, Blazing MA, Park JG, Tershakovec AM, Sabatine MS, Cannon CP, Braunwald E.
    J Am Coll Cardiol; 2021 Oct 12; 78(15):1499-1507. PubMed ID: 34620406
    [Abstract] [Full Text] [Related]

  • 20. Cardiovascular outcomes during extended follow-up of the AIM-HIGH trial cohort.
    Probstfield JL, Boden WE, Anderson T, Branch K, Kashyap M, Fleg JL, Desvigne-Nickens P, McBride R, McGovern M, AIM-HIGH Investigators.
    J Clin Lipidol; 2018 Oct 12; 12(6):1413-1419. PubMed ID: 30131256
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.